$PTLASecurity reported as PTLA
Rep. Lamar Smith disclosed that the filer purchased · $1,001 – $15,000
View transaction source status →Traded Jan 2, 2019Notified Jan 8, 2019Filed Jan 10, 20198 days to file
Owner: FilerOriginal filing ↗
Public filing record
Trade disclosures
One row per transaction reported in a 2013–2026 US House periodic transaction report, ordered by anomaly-safe activity chronology by default. The filer and the account owner are shown separately.
2013–2026Years
HouseChamber
RangeAmounts
2 matching transactions
A report can contain many transactions; these are transaction counts, not filing counts. Default chronology prevents impossible reported dates from controlling recency while keeping every source date visible.
$PTLAHaRES oF PRaXaIR EXCHaNgEd FoR 56 SHaRES oF LINdE PLC. CoMMENTS: LINdE PLC CoMbINEd LINdE ag WITH PRaXaIR oN oCTobER 31,2018. aLL PRaXaIR SToCK EXCHaNgEd FoR LINdE PLC SToCK. (oNE SHaRE FoR oNE SHaRE). SToCK VaLUE IS CoST baSIS IN PRaXaIR. Portola Pharmaceuticals, Inc. (PTLa)
Rep. Lamar Smith disclosed that the filer purchased · $1,001 – $15,000
View transaction source status →Traded Oct 3, 2018Notified Nov 7, 2018Filed Nov 8, 201836 days to file
Owner: FilerOriginal filing ↗